Placebo News and Research

RSS

Research explains the reason behind delay in therapeutic action of antidepressants

SSRI antidepressants normally take a few weeks before any showing mental health benefits, but how come it takes so long? Now a study from a group of clinicians and scientists provides the first human evidence that this is due to physical changes in the brain leading to greater brain plasticity developing over the first few weeks of SSRI intake.

9 Oct 2023

Can your body odor protect you against disease?

Whether body odor is protective against diseases.

9 Oct 2023

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

Researchers investigate whether ribavirin and pleconaril could stimulate endogenous insulin production among individuals with incident type 1 diabetes.

8 Oct 2023

Nirmatrelvir and ritonavir combo cuts COVID-19 risks for high-vulnerability groups

Nirmatrelvir and ritonavir treatment significantly reduces the risk of hospitalization and death from COVID-19 in high-risk individuals, according to a recent JAMA Network Open study. However, the treatment's efficacy varied based on the degree of vulnerability, emphasizing tailored approaches for different risk groups.

8 Oct 2023

Grape consumption improves key markers of eye health in older adults

In a recent randomized, controlled human study, consuming grapes for 16 weeks improved key markers of eye health in older adults.

6 Oct 2023

Esketamine nasal spray superior in achieving remission in patients with treatment-resistant depression

Both severe depression and treatment-resistant depression are common. Up to one third of patients do not respond to conventional therapy with antidepressants such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs).

5 Oct 2023

Early metformin therapy falls short in curbing gestational diabetes woes

In a significant randomized clinical trial, early metformin therapy was tested for its potential to lessen insulin dependence and enhance glycemic control in gestational diabetes-afflicted pregnant women; however, it yielded no improvements in diabetes symptoms. While metformin reduced maternal weight gain, its effects on primary diabetes symptoms and other secondary outcomes like infant weight gain were mixed, indicating a need for further focused research to unravel these associations.

4 Oct 2023

Antiviral treatment emerges as a potential game-changer in curbing type 1 diabetes progression

New research from the University of Oslo reveals antiviral drugs could help preserve insulin production in children newly diagnosed with type 1 diabetes, potentially slowing down or even preventing the disease. The study, building on earlier findings linking enterovirus to type 1 diabetes, showed that antiviral treatment led to maintained insulin production, proposing a new therapeutic avenue to treat and mitigate the progression of type 1 diabetes.

3 Oct 2023

Breaking the cycle of chronic back pain: new study reveals the power of shifting pain beliefs

Researchers examined whether pain processing therapy involving the reattribution of pain to processes of the brain or mind instead of being indicative of tissue damage or injury could bring pain relief and help improve the recovery process.

3 Oct 2023

New drug could transform how doctors treat grade 2 IDH-mutant gliomas

A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.

29 Sep 2023

Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat

A fast-acting medication delivered as a nasal spray may someday allow patients with intermittent rapid heartbeats to treat it themselves as soon as they develop symptoms, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

27 Sep 2023

Kombucha tea shows promise in lowering blood sugar levels for type 2 diabetics

A recent clinical trial conducted at Georgetown University Hospital suggests that kombucha tea may hold potential as an anti-hyperglycemic agent, reducing fasting blood glucose levels in adult patients with type 2 diabetes. While the results are promising, further research with larger sample sizes is needed to solidify the health benefits of kombucha in managing diabetes.

25 Sep 2023

Tirzepatide outshines other treatments in lowering blood sugar and weight for type 2 diabetes patients

Meta-analysis finds tirzepatide to be the most effective GLP-1 receptor agonist for glucose and weight control in type 2 diabetes patients. The study suggests tirzepatide could be preferable in initial stages of the disease, while other GLP-1 receptor agonists combined with insulin are equally effective for long-term diabetics.

25 Sep 2023

Plant-based proteins boost muscle mass and cut fat in older adults

Plant-based proteins are just as effective as animal-based options in maintaining muscle mass and strength in older adults, a new meta-analysis finds. The study shows that plant proteins can even aid in reducing fat mass, offering a sustainable and healthful option for combating age-related muscle decline.

24 Sep 2023

Tirzepatide superior to semaglutide for blood sugar control and body weight loss

A new meta-analysis combining 22 studies, to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October), shows that tirzepatide is superior to semaglutide for both control of blood sugar and in terms of amount of body weight lost by patients.

22 Sep 2023

Clinical study launched to test the benefits of immune modulation for hospitalized COVID-19 patients

A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial.

22 Sep 2023

Could creatine supplementation be the answer to post-COVID-19 fatigue?

In a recent study published in the journal Food Science & Nutrition, researchers investigated creatine supplementations as a potential intervention strategy to attenuate the clinical symptoms of post-COVID-19 fatigue syndrome.

22 Sep 2023

Inhaled fluticasone furoate falls flat in speeding up COVID-19 recovery, says ACTIV-6 trial

The ACTIV-6 trial investigated the effectiveness of inhaled fluticasone furoate on mild-to-moderate COVID-19 cases and found it did not accelerate recovery or prevent clinical progression compared to a placebo. Interestingly, vaccinated participants showed slightly faster recovery when treated with the drug, while unvaccinated participants did not.

21 Sep 2023

Pitt launches trial to test interventions for life-threatening bleeding in injured children

The No. 1 cause of death in children is trauma. There are an estimated 2,000 pediatric deaths from traumatic bleeding in the U.S. each year that are preventable with optimal care, yet there have been no large-scale clinical trials to guide the best way to resuscitate children with life-threatening bleeding from traumatic injury.

21 Sep 2023

ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients

A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.

21 Sep 2023

Placebo News and Research

Research explains the reason behind delay in therapeutic action of antidepressants

Can your body odor protect you against disease?

The potential benefits of ribavirin and pleconaril treatment on type 1 diabetes

Nirmatrelvir and ritonavir combo cuts COVID-19 risks for high-vulnerability groups

Grape consumption improves key markers of eye health in older adults

Esketamine nasal spray superior in achieving remission in patients with treatment-resistant depression

Early metformin therapy falls short in curbing gestational diabetes woes

Antiviral treatment emerges as a potential game-changer in curbing type 1 diabetes progression

Breaking the cycle of chronic back pain: new study reveals the power of shifting pain beliefs

New drug could transform how doctors treat grade 2 IDH-mutant gliomas

Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat

Kombucha tea shows promise in lowering blood sugar levels for type 2 diabetics

Tirzepatide outshines other treatments in lowering blood sugar and weight for type 2 diabetes patients

Plant-based proteins boost muscle mass and cut fat in older adults

Tirzepatide superior to semaglutide for blood sugar control and body weight loss

Clinical study launched to test the benefits of immune modulation for hospitalized COVID-19 patients

Could creatine supplementation be the answer to post-COVID-19 fatigue?

Inhaled fluticasone furoate falls flat in speeding up COVID-19 recovery, says ACTIV-6 trial

Pitt launches trial to test interventions for life-threatening bleeding in injured children

ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News